OFFICIAL PUBLICATION OF

by its subsidiary APPco

PBS clarifies biosimilar warning codes

Nicholas O’Donoghue 08/12/2023

Warning codes not always a block on biosimilar substitution, Pharmaceutical Benefits Scheme (PBS) says Pharmacists receiving PBS warning reason codes 162 and 163 when substituting a biosimilar for a reference brand are being urged to ensure they have the correct item code of the dispensed product. In a statement issued by the Department of Health

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

PBS clarifies biosimilar warning codes

Previous Ex netball chief scores Guild role

Next Whale swallows minnow; the Sigma CWH reverse takeover

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Ex netball chief scores Guild role

Next Whale swallows minnow; the Sigma CWH reverse takeover

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.